London
13 °C
Manchester
14 °C
Glasgow
21 °C
Dublin
Belfast
Washington
Denver
Atlanta
Dallas
Houston Texas
New Orleans
El Paso
Phoenix
Los Angeles
16 °C
12 °C
29 °C
7 °C
0 °C
26 °C
23 °C
Featured
Last news
Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
WINNIPEG, MB / ACCESS Newswire / May 21, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended March 31, 2026 and will have a conference call to present the Financial Results on May 25, 2026 at 8:30 am Eastern Time.
HealthJoy's Benefits Operating System Drives 18% Savings on Medical Procedures Through Intelligent Steerage
Independent analysis confirms HealthJoy saves $327 per employee per year by influencing heavy utilizers and high-volume care categories
UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase
AMD Telemedicine software and related systems now fully integrated; UniDoc Connect used at more than 800 sites across 48 countries
INEO Announces Q3 2026 Financial Results Release Date and Investor Webinar
SURREY, BC / ACCESS Newswire / May 21, 2026 / INEO Tech Corp. (TSXV:INEO)(OTCQB:INEOF) (the "Company" or "INEO"), a retail technology company modernizing store entrance infrastructure through connected loss prevention, digital media and operational intelligence solutions, today announced it will release its financial results for the Company's fiscal third quarter ended March 31, 2026 on Thursday, May 28, 2026.
UN members reinforce nations' climate change obligations
The United Nations General Assembly on Wednesday adopted a resolution reinforcing states' obligations to combat climate change, a long-awaited move toned down under pressure from major greenhouse gas emitters.
Ubisoft counts cost of restructuring with record annual loss
French games giant Ubisoft on Wednesday reported a record annual loss of almost 1.5 billion euros ($1.7 billion) for its 2025-26 financial year, in the midst of a far-reaching restructuring, game delays and cancellations.
Ubisoft reports record annual loss after game delays, cancellations
French games giant Ubisoft on Wednesday reported a record annual loss of almost 1.5 billion euros ($1.7 billion) for its 2025-26 financial year, in the midst of a far-reaching restructuring.
Bangladesh measles deaths near 500 but vaccines offer hope
Bangladesh has rolled out a mass vaccination campaign to combat its deadliest measles outbreak in decades that has killed nearly 500 children in just two months, the United Nations children's agency said Wednesday.
Pressure mounts at United Nations for climate change 'lifeline'
The United Nations General Assembly on Wednesday considers a resolution reinforcing states' obligations to combat climate change, a long-awaited move toned down under pressure from major greenhouse gas emitters.
Acting US attorney general defends fund for prosecuted Trump allies
Acting US Attorney General Todd Blanche on Tuesday defended the creation of a nearly $1.8 billion fund to compensate political allies of President Donald Trump who believe they were unfairly prosecuted under the Biden administration.
Jaguar Health Reports First Quarter 2026 Financials
Net revenue increased 816% in Q1 2026 vs. Q1 2025, and increased 527% in Q1 2026 vs. Q4 2025, buoyed by license of U.S. commercial rights for Mytesi® and Canalevia®-CA1Company continues its focus on crofelemer development efforts for rare-disease intestinal failure indications; two crofelemer presentations in pediatric intestinal failure patients with microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF) to be made at 58th Annual European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN) Meeting in June 2026REMINDERS: Jaguar to host investor webcast Tuesday, May 26 at 8:30 a.m. Eastern regarding Q1 2026 financials and company updates (click here to register); Jaguar CEO Lisa Conte to present virtually on Thursday, May 28 at 10 a.m. Eastern at Lytham Partners Spring 2026 Investor Conference (click here to register)
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures
Company to advance additional preclinical studies and pursue government partnership opportunities for bucillamine as a potential franchise asset for infectious diseases, nerve-agent exposure, future pandemics and medical countermeasure stockpiling
Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association
Collaboration with USEA for Zomedica's PulseVet® shock wave system will increase brand awareness among Eventing enthusiasts.
Shock and bafflement at San Diego mosque where three were killed
Outside the San Diego mosque where his father was gunned down by heavily armed teenagers who had been radicalized online, Ramzy sits and stares blankly.
Google wants its search bar to act on your behalf in AI revamp
Google on Tuesday showed off new plans to turn its famous search bar into an AI assistant that can book restaurants, track news and contact businesses -- just by asking a question.
Pakistan court sentences man to death for killing teen influencer
A Pakistani court sentenced a man to death on Tuesday for murdering a teenage influencer last year after she had repeatedly rejected his advances.
Mango founder's son arrested in Spain over father's death
Spanish police said Tuesday they have arrested the eldest son of Mango clothing empire founder Isak Andic over his father's death during a hiking trip in December 2024.
US police investigating deadly mosque shooting as hate crime
Police were investigating a shooting in the US state of California as a hate crime on Tuesday after a pair of teenage gunmen killed three people at a mosque complex.
Government encourages women to report rape in French star's assault probes
The French government spokeswoman on Tuesday encouraged women to speak out about sexual violence, "even decades later," as she addressed mounting allegations of rape and assault targeting popular singer and actor Patrick Bruel.
Three killed in San Diego mosque shooting, both suspects dead
A shooting Monday at a mosque complex in southern California killed three people, with two suspected teenage gunmen later found dead in a car from apparent self-inflicted gunshot wounds, police said.
Campaigners warn Italy's gutted rape bill could help assailants
An attempt in Italy to introduce a consent-based rape law is floundering and experts warn rapists could stand to gain after the far right torpedoed an "only yes means yes" definition.
Libyan ex-prison boss faces ICC war crimes hearing
A former boss of a notorious Libyan prison faces three days of hearings at the International Criminal Court from Tuesday, accused of war crimes including murder, rape and torture.
Star of Rome's 'sexy priest' calendar admits: 'I was never a priest'
His face smiles out from every kiosk in Rome on the cover of the ubiquitous "sexy priest" calendar sold to tourists but Giovanni Galizia was never a man of the cloth.
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
VANCOUVER, BC / ACCESS Newswire / May 19, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated April 28, 2026, continued progress in the intermediate1 scale-up and process development activities for the A83 and B4 precursor components supporting the Company's lead oncology program, ONC010, a novel nanoparticle-formulated PNKP inhibitor currently advancing through IND-enabling development.
Bouka Family Sets Out Again to Conquer Everest
Inspiring resilience
AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform
Acquisition extends AP Technologies' vertically integrated catheter platform into nitinol and precision laser processing. Dundalk, Ireland joins the company's network of Centers of Excellence as its first European operation.
Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
First MVID patient enters the active treatment only extension phase after completion of randomized double-blind crossover period to evaluate longer-term safety and efficacy with liquid oral crofelemer as adjunctive treatment for MVID, an ultrarare pediatric disease with a lethal natural history and no approved therapies, requiring lifelong parenteral support (PS)
BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development
VANCOUVER, BC / ACCESS Newswire / May 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that its Semaglutide oral dissolvable film ("ODF") program has entered the active pharmaceutical development phase in collaboration with German drug development partner Gen-Plus GmbH.
Harry Styles fans to splash over £1 bn on London concerts: Barclays
Harry Styles' dozen concerts in London this summer will see fans spend more than £1.0 billion ($1.3 billion) combined on tickets and costs including accommodation and travel, Barclays forecast Tuesday.
Three killed in San Diego mosque shooting, two attackers dead
A shooting at a mosque complex in California killed three people Monday, with two suspected teenage gunmen later found dead in a car from self-inflicted gunshot wounds, police said.
After mayor's murder, Mexico battles to bring peace
The brazen murder of a small-city mayor shocked Mexico and forced President Claudia Sheinbaum to step up an offensive against all-powerful drug cartels.
Musk loses blockbuster OpenAI suit as jury says too late
A federal jury ruled Monday that Elon Musk waited too long to sue OpenAI and its co-founders, delivering a decisive victory to OpenAI CEO Sam Altman and ending one of Silicon Valley's most closely watched courtroom battles.